Bridges Investment Counsel’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$403K Sell
2,125
-100
-4% -$19.2K 0.22% 95
2017
Q3
$421K Sell
2,225
-6,110
-73% -$1.11M 0.23% 92
2017
Q2
$1.45M Buy
8,335
+3,900
+88% +$655K 0.33% 75
2017
Q1
$681K Sell
4,435
-2,800
-39% -$428K 0.2% 82
2016
Q4
$1.02M Buy
+7,235
New +$1.07M 0.25% 89

Other funds holding TMO

Bridges Investment Counsel's TMO Position: Q4 2017 in Review

Bridges Investment Counsel reduced its Thermo Fisher Scientific (TMO) stake by 4.5% in Q4 2017, selling an estimated $19.2K and leaving 2,125 shares worth $403K. The position accounts for 0.22% of the portfolio, ranked #95.

Bridges Investment Counsel first reported a position in TMO in Q4 2016 and has held it in 5 quarters since. The position peaked at $1.45M in Q2 2017. 1,246 funds tracked by Wall St. Rank hold TMO as of Q4 2017.

  • Bridges Investment Counsel held 2,125 shares of Thermo Fisher Scientific worth $403K as of Q4 2017.
  • Bridges Investment Counsel sold 100 Thermo Fisher Scientific shares in Q4 2017, an estimated $19.2K.
  • Thermo Fisher Scientific made up 0.22% of Bridges Investment Counsel's portfolio in Q4 2017, its #95 holding.
  • Bridges Investment Counsel first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 5 quarters since.
  • Bridges Investment Counsel's Thermo Fisher Scientific position peaked at $1.45M in Q2 2017.
  • 1,246 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2017.

Based on Bridges Investment Counsel's 13F filing for Q4 2017, filed 9 Feb 2018.